Assessment by a New ELISA Method of Clinical Relevance of Serum Concentration of Adipocyte Fatty Acid Binding Protein in Patients with Metabolic Syndrome Diagnosis

Authors

  • David Stejskal Department of Laboratory Medicine, Hospital, Šternberk
  • Michal Karpíšek Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno
  • Peter Kollár Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno

Keywords:

ELISA, metabolic syndrome

Abstract

Development, composition, validation and clinical relevance of the first ELISA method for measurement of adipocyte fatty acid binding protein (A-FABP) concentration in serum is presented. First results of clinical testing confirm the hypothesis on the possible use of A-FABP as a marker of metabolic syndrome.

Downloads

Published

2006-12-15

How to Cite

Stejskal, D., Karpíšek, M., & Kollár, P. (2006). Assessment by a New ELISA Method of Clinical Relevance of Serum Concentration of Adipocyte Fatty Acid Binding Protein in Patients with Metabolic Syndrome Diagnosis . Chemické Listy, 100(12), 1116–1119. Retrieved from http://w.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/4380

Issue

Vol. 100 No. 12 (2006)

Section

Articles

Most read articles by the same author(s)